BETA: Please send your feedback!

Edge Therapeutics

NAS:EDGE

Biotechnology

$12.69mm
SMALL cap
$0.41 (-1.82%)
12.2817%
since start of 2019
  • 2
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data Privacy
  • Consumer Health
  • Employee Satisfaction
  • Workplace Safety
  • Corp Gov
  • Ethical Practices
  • Conflict Materials
  • Forced Labor
  • Gender Diversity
  • 2
  • CF
  • PP
  • WC
  • DP
  • CH
  • ES
  • WS
  • CG
  • EP
  • CM
  • FL
  • GD
  • 1
  • 2
  • 3
  • 4
  • 5

About

Edge Therapeutics, Inc. operates as biotechnology company which develops therapies. engages in the discovery, development, and commercialize novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological conditions for which limited or no current therapies exist. It develops the Precisa Platform of EG-1962 and the EG-1964 treatments. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ.
website

Headquarters

300 Connell Drive
Suite 1600
Berkeley Heights, NJ 07922

Executives

Name Title Gender
Albert N. Marchio, II, MBA CFO, Chief Accounting & Administrative Officer Male
Sol J. Barer, PhD Chairman Male
W. Bradford Middlekauff Secretary, Senior Vice President & General Counsel Male
Gregory W. Gin Investor Relations Officer Male
Brian A. Leuthner, MBA President, Chief Executive Officer & Director Male
Robert Loch Macdonald, PhD Director & Chief Scientific Officer Male
Carl J. Soranno Founder Male
Herbert J. Faleck, MD Chief Medical Officer Male
Daniel Brennan, MBA Chief Operating Officer Male
Renu Vaish Vice President-Global Regulatory Affairs Female
Alyssa Wyant Senior Vice President-Regulatory Affairs Female

Mindful Investing Summary

  • 1
  • 2
  • 3
  • 4
  • 5
  • Carbon Footprint N/A
  • Pollution Prevention N/A
  • Water Conservation N/A
  • Data & Privacy Protection N/A
  • Consumer Health, Wellness & Safety N/A
  • Employee Ownership, Satisfaction, Benefits & Pay N/A
  • Workplace Health and Safety N/A
  • Integrity of Corporate Governance N/A
  • Ethical Practices N/A
  • Usage of Conflict Materials N/A
  • Forced Labor N/A
  • Diversity of Corporate Leadership 2

Edge Therapeutics - Competitors and Related Companies

How Edge Therapeutics stacks up to its peers in the Biotechnology industry or with competing business segments.

Edge Therapeutics

NAS:EDGE

Biotechnology

$12.69mm
SMALL cap
$0.41 (-1.82%)
12.2817%
since start of 2019
  • 2
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data Privacy
  • Consumer Health
  • Employee Satisfaction
  • Workplace Safety
  • Corp Gov
  • Ethical Practices
  • Conflict Materials
  • Forced Labor
  • Gender Diversity
  • 2
  • CF
  • PP
  • WC
  • DP
  • CH
  • ES
  • WS
  • CG
  • EP
  • CM
  • FL
  • GD
  • 1
  • 2
  • 3
  • 4
  • 5
Loading…